| Revenue growth | Value |
|---|---|
| 1Y (TTM) | +8% |
| 3Y CAGR | -13% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | +67% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
PfizerPFIZER | ₹4,799.30 -29.80 (0.62%) | 21,962.57 | 29.87 | 5.23 | ||
Caplin Point LaboratoriesCAPLIPOINT | ₹2,529.70 +7.70 (0.31%) | 19,232.10 | 28.36 | 5.36 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹7,645.00 +4.50 (0.06%) | 19,124.63 | 112.75 | 21.91 | ||
Natco PharmaNATCOPHARM | ₹898.35 +8.55 (0.96%) | 16,080.48 | 14.05 | 1.74 |